FDA Approves GORE(R) CARDIOFORM Septal Occluder for PFO Closure to Prevent Recurrent Ischemic Stroke

Gore REDUCE Clinical Study demonstrated 77 percent relative reduction in recurrent ischemic stroke when PFO closure was combined with antiplatelet therapy, compared to antiplatelet therapy alone FLAGSTAFF, Ariz., April 3, 2018 -- (Healthcare Sales & Mar... Devices, Interventional, Cardiology, FDA W. L. Gore, patent foramen ovale, CARDIOFORM, Septal Occluder
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news